Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
ViewAttendees 1

Z6. COVID-19 Diagnostics

Session: Research in COVID-19 Diagnostics

144 - Clinical Validation and Performance of a T-cell Immunosequencing Assay to Identify Past SARS-CoV-2 Infection

On Demand
Participants should be aware of the following financial/non-financial relationships:
Sudeb C. Dalai, MD, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Jennifer N. Dines, MD: Adaptive Biotechnologies (Employee, Shareholder)
Thomas M. Snyder, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Rachel M. Gittelman, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Tera Eerkes, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Pashmi Vaney, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Sally Howard, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Kipp Akers, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Lynell Skewis, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Anthony Monteforte, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Pamela R. Witte, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Cristina Wolf, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Hans Nesse, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Jia Qadeer, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Sarah Duffy, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Emily Svejnoha, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Caroline Taromino, PhD: Adaptive Biotechnologies (Employee, Shareholder)
Michael Kagen, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ian M. Kaplan, PhD: Adaptive Biotechnologies (Employee, Shareholder)
John Alsobrook, MD: Adaptive Biotechnologies (Employee, Shareholder)
Thomas Manley, MD: Adaptive Biotechnologies (Employee, Shareholder)
Lance Baldo, MD: Adaptive Biotechnologies (Employee, Shareholder, Leadership Interest)

    Presenting Author(s)

  • Sudeb C. Dalai, MD, PhD

    Senior Medical Director
    Adaptive Biotechnologies and Stanford University School of Medicine
    Seattle, WA, United States

    Adaptive Biotechnologies (Employee, Shareholder)

    Slides Slides and Audio

    • Co-Author(s)

  • JD

    Jennifer N. Dines, MD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • Thomas M. Snyder, PhD

    VP, Research
    Adaptive Biotechnologies
    Seattle, WA, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • RG

    Rachel M. Gittelman, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • TE

    Tera Eerkes, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • PV

    Pashmi Vaney, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • SH

    Sally Howard, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • KA

    Kipp Akers, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • LS

    Lynell Skewis, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • AM

    Anthony Monteforte, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • PW

    Pamela R. Witte, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • CW

    Cristina Wolf, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • HN

    Hans Nesse, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • JQ

    Jia Qadeer, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • SD

    Sarah Duffy, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • ES

    Emily Svejnoha, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • CT

    Caroline Taromino, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • MK

    Michael Kagen, MD

    Kagen MD
    Park City, Utah, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • IK

    Ian M. Kaplan, PhD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • JA

    John Alsobrook, MD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • TM

    Thomas Manley, MD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder)

  • LB

    Lance Baldo, MD

    Adaptive Biotechnologies
    Seattle, Washington, United States

    Adaptive Biotechnologies (Employee, Shareholder, Leadership Interest)